Search research articles
Contact Us
Filters
Showing results (101-110 of 193) with videos related to
Page
of 20
Sort By:
European Journal of Nuclear Medicine and Molecular Imaging
|
July 13, 2006
Improved tumour detection by gastrin receptor scintigraphy in patients with metastasised medullary thyroid carcinoma
Martin Gotthardt, Martin P Béhé, Daniela Beuter, et al.
Bone Reports
|
June 30, 2018
Evaluation of bone mineralization in former preterm born children: Phalangeal quantitative ultrasound cannot replace dual-energy X-ray absorptiometry
Carmen M T Lageweg, Mayke E van der Putten, Johannes B van Goudoever, et al.
Nuclear Medicine Communications
|
April 22, 2004
18F-FDG PET, somatostatin receptor scintigraphy, and CT in metastatic medullary thyroid carcinoma: a clinical study and an analysis of the literature
Martin Gotthardt, Anke Battmann, Helmut Höffken, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
April 3, 2007
Indication for different mechanisms of kidney uptake of radiolabeled peptides
Martin Gotthardt, Julliëtte van Eerd-Vismale, Wim J G Oyen, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
March 23, 2011
Scintigraphic techniques for early detection of cancer treatment-induced cardiotoxicity
Lioe-Fee de Geus-Oei, Annelies M C Mavinkurve-Groothuis, Louise Bellersen, et al.
Endocrine-Related Cancer
|
December 13, 2006
Added value of gastrin receptor scintigraphy in comparison to somatostatin receptor scintigraphy in patients with carcinoids and other neuroendocrine tumours
Martin Gotthardt, Martin P Béhé, Julia Grass, et al.
Theranostics
|
January 7, 2020
PET/MRI enables simultaneous <i>in vivo</i> quantification of β-cell mass and function
Filippo C Michelotti, Gregory Bowden, Astrid Küppers, et al.
European Radiology
|
August 7, 2014
Amplitude-based optimal respiratory gating in positron emission tomography in patients with primary lung cancer
Willem Grootjans, Lioe-Fee de Geus-Oei, Antoi P W Meeuwis, et al.
European Thyroid Journal
|
February 10, 2026
Clinical Presentation and Outcomes of Medullary Thyroid Cancer in Two European Countries: Impact of Diagnostic Strategies
Daniele Ceruti, Han J Bonenkamp, Carla Colombo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 19, 2007
[Lys40(Ahx-DTPA-111In)NH2]-Exendin-4 is a highly efficient radiotherapeutic for glucagon-like peptide-1 receptor-targeted therapy for insulinoma
Andreas Wicki, Damian Wild, Daniel Storch, et al.
Page
of 20
Search research articles
Search
Showing results (101-110 of 193) with videos related to
Sort By:
Page
of 20
European Journal of Nuclear Medicine and Molecular Imaging
|
July 13, 2006
Improved tumour detection by gastrin receptor scintigraphy in patients with metastasised medullary thyroid carcinoma
Martin Gotthardt, Martin P Béhé, Daniela Beuter, et al.
Bone Reports
|
June 30, 2018
Evaluation of bone mineralization in former preterm born children: Phalangeal quantitative ultrasound cannot replace dual-energy X-ray absorptiometry
Carmen M T Lageweg, Mayke E van der Putten, Johannes B van Goudoever, et al.
Nuclear Medicine Communications
|
April 22, 2004
18F-FDG PET, somatostatin receptor scintigraphy, and CT in metastatic medullary thyroid carcinoma: a clinical study and an analysis of the literature
Martin Gotthardt, Anke Battmann, Helmut Höffken, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
April 3, 2007
Indication for different mechanisms of kidney uptake of radiolabeled peptides
Martin Gotthardt, Julliëtte van Eerd-Vismale, Wim J G Oyen, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
March 23, 2011
Scintigraphic techniques for early detection of cancer treatment-induced cardiotoxicity
Lioe-Fee de Geus-Oei, Annelies M C Mavinkurve-Groothuis, Louise Bellersen, et al.
Endocrine-Related Cancer
|
December 13, 2006
Added value of gastrin receptor scintigraphy in comparison to somatostatin receptor scintigraphy in patients with carcinoids and other neuroendocrine tumours
Martin Gotthardt, Martin P Béhé, Julia Grass, et al.
Theranostics
|
January 7, 2020
PET/MRI enables simultaneous <i>in vivo</i> quantification of β-cell mass and function
Filippo C Michelotti, Gregory Bowden, Astrid Küppers, et al.
European Radiology
|
August 7, 2014
Amplitude-based optimal respiratory gating in positron emission tomography in patients with primary lung cancer
Willem Grootjans, Lioe-Fee de Geus-Oei, Antoi P W Meeuwis, et al.
European Thyroid Journal
|
February 10, 2026
Clinical Presentation and Outcomes of Medullary Thyroid Cancer in Two European Countries: Impact of Diagnostic Strategies
Daniele Ceruti, Han J Bonenkamp, Carla Colombo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 19, 2007
[Lys40(Ahx-DTPA-111In)NH2]-Exendin-4 is a highly efficient radiotherapeutic for glucagon-like peptide-1 receptor-targeted therapy for insulinoma
Andreas Wicki, Damian Wild, Daniel Storch, et al.
Page
of 20